INSTITUTION'S PROFILE
Eswatini Prevention Center, International Center for AIDS Care and Treatment Program at Columbia University Mailman School of Public Health, New York, NY, USA.
Publications (1)
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.
Journal: Lancet (London, England)
Publication date: 2022
Journal: Lancet (London, England)
Publication Year: 2022